Integral Health Asset Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.4M Buy
4,300,000
+1,300,000
+43% +$9.05M 1.31% 19
2025
Q4
$21.1M Buy
3,000,000
+1,500,000
+100% +$9.05M 1.05% 33
2025
Q3
$8.25M Buy
+1,500,000
New +$7.35M 0.56% 58
2023
Q4
Sell
-1,300,000
Closed -$8.93M 80
2023
Q3
$8.93M Buy
1,300,000
+527,000
+68% +$4.27M 1.24% 31
2023
Q2
$7.06M Buy
773,000
+64,000
+9% +$532K 0.87% 45
2023
Q1
$5.27M Buy
+709,000
New +$3.93M 1.06% 39
2022
Q4
Sell
-525,000
Closed -$3.48M 80
2022
Q3
$3.48M Buy
525,000
+149,272
+40% +$1.04M 0.68% 52
2022
Q2
$2.09M Buy
375,728
+225,728
+150% +$1.73M 0.43% 57
2022
Q1
$1.52M Buy
+150,000
New +$1.32M 0.39% 60
2021
Q4
Sell
-350,000
Closed -$5.08M 78
2021
Q3
$5.08M Buy
+350,000
New +$6.74M 1.46% 25

Other funds holding LFST

Integral Health Asset Management's LFST Position: Q1 2026 in Review

Integral Health Asset Management increased its Lifestance Health (LFST) stake by 43% in Q1 2026, buying an estimated $9.05M and bringing the position to 4,300,000 shares worth $27.4M. The position accounts for 1.31% of the portfolio, ranked #19.

Integral Health Asset Management first reported a position in LFST in Q3 2021 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Integral Health Asset Management held 4,300,000 shares of Lifestance Health worth $27.4M as of Q1 2026.
  • Integral Health Asset Management bought 1,300,000 Lifestance Health shares in Q1 2026, an estimated $9.05M.
  • Lifestance Health made up 1.31% of Integral Health Asset Management's portfolio in Q1 2026, its #19 holding.
  • Integral Health Asset Management first reported a position in Lifestance Health in Q3 2021 and has held it in 10 quarters since.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.